Intestinal barrier dysfunction and differential CLDN8 and MUC1 expression in vedolizumab responsiveness among inflammatory bowel disease patients: a proof-of-concept study.

Saved in:
Bibliographic Details
Title: Intestinal barrier dysfunction and differential CLDN8 and MUC1 expression in vedolizumab responsiveness among inflammatory bowel disease patients: a proof-of-concept study.
Authors: Shahabudin NA; Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia., Raja Ali RA; GUT Research Group, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia.; Sir Jeffery Cheah Sunway Medical School, School of Medical and Life Sciences, Sunway University, 47500 Sunway City, Selangor, Malaysia.; Division of Gastroentero-Hepatology, Department of Internal Medicine, Universitas Airlangga, Surabaya, Indonesia., Tan GC; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia., Mokhtar NM; International Medical School, Management and Science University, 40000 Shah Alam, Selangor, Malaysia. norfilza@msu.edu.my.
Source: The Malaysian journal of pathology [Malays J Pathol] 2026 Apr; Vol. 48 (1), pp. 37-52.
Publication Type: Journal Article
Journal Info: Publisher: Academy of Medicine of Malyasia, College of Pathologists Country of Publication: Malaysia NLM ID: 8101177 Publication Model: Print Cited Medium: Internet ISSN: 0126-8635 (Print) Linking ISSN: 01268635 NLM ISO Abbreviation: Malays J Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0126-8635